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Background:  Current guidelines consider diabetes as a coronary artery disease (CAD) risk equivalent, but cardiovascular risk in patients with 
diabetes may vary substantially depending on the presence of subclinical CAD at baseline.
Methods:  Vascular events were recorded over 8 years in 750 consecutive patients undergoing coronary angiography for the evaluation of 
established or suspected stable CAD.
Results:  From our patients, 244 had neither type 2 diabetes (T2DM) nor significant CAD (i.e. coronary stenoses ≥50%) at the baseline 
angiography, 50 had T2DM but not significant CAD, 342 did not have T2DM but had significant CAD, and 114 had both T2DM and significant CAD. 
Non-diabetic subjects without significant CAD had an event rate of 20.5%. The event rate was similar in T2DM patients without significant CAD 
(22.0%; p = 0.811), but higher in non-diabetic patients with significant CAD (39.5%, p <0.001). Patients with T2DM plus significant CAD had the 
highest event rate (53.5%; p <0.001). Importantly, T2DM patients without significant CAD had a significantly lower event rate than non-diabetic 
patients with significant CAD (p = 0.017).
Conclusion: T2DM per se is not a CAD risk equivalent. Moderate risk diabetic patients without significant CAD and very high-risk diabetic 
patients with significant CAD add up to a grand total of high risk diabetic patients: this is why diabetes appears as a CAD risk equivalent in many 
epidemiological studies.
